PGRN has potential therapeutic activity in neurodegenerative diseases since it has been found that viral vector gene delivery of GRN suppresses the development of disease-like phenotypes in murine models of Parkinson’s disease (PD) [2] and Alzheimer’s disease [3]. This evidence concerns the gene GRN and Alzheimer disease.